This study examines the use of Silexan, a lavender oil medication, in people with Major Depressive Disorder of mild to moderate severity. The study will evaluate whether taking a daily 80 mg soft capsule of Silexan works better than a placebo in reducing depression symptoms.
The purpose of this research is to determine if Silexan is effective and safe for treating mild to moderate depression. During the study, participants will take either Silexan or a placebo capsule once daily for 8 weeks. The depression symptoms will be monitored throughout the study period using various assessment tools that measure the severity of depression and how it affects daily life.
The study will track any changes in depression symptoms and monitor the overall safety of the treatment. Researchers will observe how participants respond to the medication, including whether their depression symptoms improve or if they achieve remission (very low levels of depression symptoms). They will also keep track of any side effects that may occur during the treatment period.
Austria 
Germany 
